Search Results

Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.

• Authors : Kent, David M. (); Saver, Jeffrey L. (); Kasner, Scott E. ()

Subjects: DISEASE relapse -- Prevention; FIBRINOLYTIC agents -- Therapeutic use; RESEARCH

• Source: JAMA: Journal of the American Medical Association. 12/14/2021, Vol. 326 Issue 22, p2277-2286. 10p.

Record details

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.

• Authors : Duarte-Salles, Talita; Vizcaya, David; Pistillo, Andrea

Subjects: RISK factors of pneumonia; FIBRINOLYTIC agents -- Therapeutic use; HOSPITALSSOUTH Korea

• Source: Pediatrics. Sep2021, Vol. 148 Issue 3, p1-15. 15p.

Record details

Cerebral Amyloid Angiopathy and Transient Neurological Events: Can Intracerebral Hemorrhage Risk Be Predicted?

Subjects: *FIBRINOLYTIC agents; *NEUROLOGICAL disorders; *CEREBRAL hemorrhage

• Source: Neurology Alert. Apr2022, Vol. 41 Issue 8, p1-3. 3p.

Record details

practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.

• Authors : Noh, Lydia; Pham, Felix; Haddad, Lara

Subjects: FIBRINOLYTIC agents -- Therapeutic use; ISCHEMIC stroke; UNITED States. Food & Drug Administration

• Source: American Journal of Health-System Pharmacy. May2022, Vol. 79 Issue 9, pe149-e153. 5p. 3 Charts.

Record details

Outcomes of leadless pacemaker implantation in patients with mechanical heart valves.

• Authors : Loughlin, Gerard; Pachón, Marta; Martínez‐Sande, José Luis

Subjects: FIBRINOLYTIC agents -- Therapeutic use; ELECTRODES; RESEARCHSPAIN

• Source: Journal of Cardiovascular Electrophysiology. May2022, Vol. 33 Issue 5, p997-1004. 8p. 3 Charts, 1 Graph.

Record details

Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury.

• Authors : Stubbs, D. J. (); Davies, B. M. (); Menon, D. K. ()

Subjects: SUBDURAL hematoma; BRAIN injuries; HEALTH care teamsUNITED Kingdom

• Source: Anaesthesia. 2022 Supplement 1, Vol. 77, p21-33. 13p.

Record details

Antithrombotic selection in patients undergoing transcatheter aortic valve replacement.

• Authors : Lai, Jennifer K; Willenborg, Katie L; Berei, Theodore

Subjects: FIBRINOLYTIC agents -- Therapeutic use; HEMORRHAGE prevention; ISCHEMIA prevention

• Source: American Journal of Health-System Pharmacy. Jan2021, Vol. 78 Issue 1, p22-35. 14p. 1 Diagram, 4 Charts.

Record details

Mortality Reduction Associated with Coexistent Antithrombotic Use in Nursing Home Residents with COVID-19.

• Authors : Adler, Laurent¹ (AUTHOR); Lipton, Cathy¹ (AUTHOR); Watson, Clay C.¹ (AUTHOR)

Subjects: *FIBRINOLYTIC agents; *COVID-19; *CONFERENCES & conventionsMARYLAND

• Source: Journal of the American Medical Directors Association. Mar2022, Vol. 23 Issue 3, p440-441. 2p.

Record details

Repeat CT after blunt head trauma and Glasgow Coma Scale score 13–15 without neurological deterioration is very low yield for intervention.

• Authors : Karanci, Yusuf; Oktay, Cem

Subjects: FIBRINOLYTIC agents -- Therapeutic use; EVALUATION of medical care; BLUNT traumaTURKEY

• Source: European Journal of Trauma & Emergency Surgery; Apr2022, Vol. 48 Issue 2, p1069-1076, 8p, 1 Diagram, 3 Charts

Record details

Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study.

• Authors : García Rodríguez, Luis A.; Cea Soriano, Lucía; de Abajo, Francisco J.

Subjects: FIBRINOLYTIC agents -- Therapeutic use; STATINS (Cardiovascular agents); ORAL drug administrationEUROPE; SPAIN; DENMARK

• Source: European Journal of Clinical Pharmacology; Mar2022, Vol. 78 Issue 3, p497-504, 8p, 4 Graphs

Record details